Sales rise 213.09% to Rs 25.36 crore
Net Loss of Bharat Immunological & Biological Corporation reported to Rs 3.87 crore in the quarter ended September 2020 as against net loss of Rs 5.66 crore during the previous quarter ended September 2019. Sales rose 213.09% to Rs 25.36 crore in the quarter ended September 2020 as against Rs 8.10 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales25.368.10 213 OPM %-17.74-82.47 -PBDT-5.53-7.76 29 PBT-5.59-7.82 29 NP-3.87-5.66 32Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
